Table 1.
Patients | N (%) | 266 |
Sex (F) | N (%) | 183/266 (68.8) |
Age at onset (years) | Median (IQR) | 32.93 (25.5–42.5) |
Disease duration (months) | Median (IQR) | 4.97 (1.27–25.08) |
Unique CSF OCB, present | N (%) | 190/261 (72.8) |
EDSS | Median (IQR) | 1.5 (1–2.5) |
Clinical disease activity, yes | N (%) | 94/263 (35.7) |
Radiological disease activity, yes | N (%) | 108/252 (42.9) |
BREMS at onset | Median (IQR) | 0.02 (−0.55 to 0.58) |
BREMSO, Bayesian risk estimate for MS at onset; CSF, cerebrospinal fluid; EDSS, Expanded Disability Status Scale; MS, multiple sclerosis; OCB, oligoclonal bands; RR, relapsing-remitting.